COVID-19 Update: We are currently shipping orders daily. However, due to transit disruptions in some geographies, deliveries may be delayed. To provide all customers with timely access to content, we are offering 50% off Science and Technology Print & eBook bundle options. Terms & conditions.
Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease - 6th Edition - ISBN: 9780128139554, 9780128139561

Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease

6th Edition

Volume 1

Editors: Roger N. Rosenberg Juan M. Pascual
Hardcover ISBN: 9780128139554
eBook ISBN: 9780128139561
Imprint: Academic Press
Published Date: 23rd June 2020
Page Count: 1012
Sales tax will be calculated at check-out Price includes VAT/GST
Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.


Rosenberg’s Molecular and Genetic Basis of Neurologic and Psychiatric Disease, Sixth Edition: Volume One, provides a comprehensive introduction and reference to the foundations and key practical aspects relevant to neurologic and psychiatric disease. A favorite of over three generations of students, clinicians and scholars, this new edition retains and expands the informative, concise and critical tone of the first edition. This is an essential reference for general medical practitioners, neurologists, psychiatrists, geneticists, and related professionals, and for the neuroscience and neurology research community. The content covers all aspects essential to the practice of neurogenetics to inform clinical diagnosis, treatment and genetic counseling.

Every chapter has been thoroughly revised or newly commissioned to reflect the latest scientific and medical advances by an international team of leading scientists and clinicians. The contents have been expanded to include disorders for which a genetic basis has been recently identified, together with abundant original illustrations that convey and clarify the key points of the text in an attractive, didactic format.

Key Features

  • Comprehensive coverage of the neurogenetic foundation of neurological and psychiatric disease
  • Provides a detailed introduction on both the clinical and basic research implications of molecular and genetics surrounding the brain
  • Includes new chapters on molecular genomics, CRISPR and the most recent updates in molecular genetics


Clinical neurologists, psychiatrists, psychologists,neuroscience researchers, clinical neurology researchers, general medical practitioners, and genetic and molecular biologists with an interest in neurogenetics

Table of Contents

1. Mendelian, non-Mendelian, multigenic inheritance, and epigenetics
2. Precision medicine in neurology
3. Epigenomics of neurological disorders
4. Genotype<PHENOTYPE disease
5. Immunogenetics of neurological disease
6. Pharmacogenomic approaches to the treatment of sporadic Alzheimer’s disease
7. Application of mouse genetics to human disease: generation and analysis of mouse models
8. DNA sequencing and other methods of exonic and genomic analyses
9. Association, cause, and causal association, revised: reasoning and methods
10. Adeno-associated virus-mediated gene therapy in central nervous system genetic disorders
11. Genomics of human neurological disorders
12. CRISPR-Cas immune systems and genome engineering
13. Direct induction of neural cells from somatic cells
14. Neuroimaging in dementias
15. Cognitive enhancers, intellectual disability, and personal identity: emerging ethical issues
16. Genetic counseling
17. Antisense oligonucleotide drugs for neurological and neuromuscular disease
18. Cerebral malformations
19. Global developmental delay and intellectual disability
20. Alzheimer’s disease and down syndrome
21. An overview of Rett syndrome
22. Fragile X clinical features and neurobiology
23. Neurological evaluation and management of autism spectrum disorder
24. Angelman syndrome
25. Prion diseases
Sub-Section: Mitochondrial Disorders
26. The mitochondrial genome
27. Mitochondrial disorders due to mutations in the mitochondrial genome
28. Mitochondrial disorders due to mutations in the nuclear genome
29. Pyruvate dehydrogenase, pyruvate carboxylase, Krebs cycle, and mitochondrial transport disorders
Sub-Section: Lysosomal Disorders
30. Gaucher disease—neuronopathic forms
31. The Niemann-Pick diseases
32. GM2-gangliosidoses
33. Metachromatic leukodystrophy and multiple sulfatase deficiency
34. Krabbe disease: globoid cell leukodystrophy
35. The mucopolysaccharidoses
36. The mucolipidoses
37. Disorders of glycoprotein degradation: sialidosis, fucosidosis, α-mannosidosis, β-mannosidosis, and aspartylglycosaminuria
38. β-Galactosidase deficiency: GM1 gangliosidosis, Morquio B disease, and galactosialidosis
39. Acid ceramidase deficiency: Farber
lipogranulomatosis, spinal muscular atrophy associated with progressive myoclonic epilepsy and peripheral osteolysis
40. Wolman disease
41. Lysosomal membrane disorders: lysosome associated membrane protein-2 deficiency (Danon disease)
42. Fabry disease: α-galactosidase A deficiency
43. Schindler disease: deficient α-Nacetylgalactosaminidase activity
Sub-Section: Metal Metabolism Disorders
44. Wilson disease
45. Menkes disease and other ATP7A disorders
46. Neurodegeneration with brain iron accumulation
47. Pantothenate kinase-associated neurodegeneration
48. Disorders of manganese transport
49. Aceruloplasminemia
Sub-Section: Vitamin Disorders
50. Genetic and dietary influences on life span
51. Vitamins: cobalamin and folate
52. Inherited biotin-responsive disorders
53. Disorders of pyridoxine metabolism
Sub-Section: Lipid Metabolism Disorders
54. Disorders of lipid metabolism
55. Lipoprotein disorders
56. Cerebrotendinous xanthomatosis
Sub-Section: Other Metabolic Disorders
57. Organic acid disorders
58. Glycogen and polyglucosan storage diseases
59. Disorders of galactose metabolism
60. Inborn errors of amino acid metabolism phenylketonuria and disorders of biopterin metabolism
61. Urea cycle disorders
62. Glucose transporter type I deficiency and other glucose flux disorders
63. Maple syrup urine disease: biochemical, clinical and therapeutic considerations
64. Congenital disorders of N-linked glycosylation
65. Disorders of glutathione metabolism
66. Canavan disease
67. Neurotransmitter disorders
69. Purines and pyrimidines
70. The acute porphyrias


No. of pages:
© Academic Press 2020
23rd June 2020
Academic Press
Hardcover ISBN:
eBook ISBN:

About the Editors

Roger N. Rosenberg

Roger N. Rosenberg

Roger N. Rosenberg, MD is a graduate of Northwestern University Medical School, With Distinction, and was subsequently trained in Neurology with H. Houston Merritt, MD at the Neurological Institute, Columbia University, New York, was Chief Resident and then was a Post-Doctoral Fellow with Nobel Laureate Marshall Nirenberg at the NIH in the Laboratory of Biochemical Genetics. He is Board Certified by the American Board of Psychiatry and Neurology. He is holder of the Zale Distinguished Chair and Professor of Neurology and Neurotherapeutics at the University of Texas Southwestern Medical Center at Dallas since 1973 and developed the department for 18 years as Chair from 1973-1991. He described for the first time in 1975 Machado Joseph disease, an autosomal dominant cerebellar degeneration, which produces imbalance and impaired coordination, and showed it was due to a unique expansion of DNA in the causal gene. It is the most common inherited form of impaired coordination in the world and his research has provided a genetic marker to eliminate it in large families in future generations. He has served as the Founding Director of the UT Southwestern NIH funded Alzheimer’s Disease Center and Principal Investigator of the NIH Center Grant from 1987-2019. He directs an active laboratory effort in Alzheimer’s Disease. He is developing a DNA Aβ42 trimer vaccine for Alzheimer's disease for which he was awarded a US Patent "Amyloid Beta Gene Vaccines" in January 2009. It has been tested in mouse, transgenic mouse, New Zealand white rabbits and rhesus monkeys. The vaccine produces effective anti-Aβ42 peptide antibody levels and is non-inflammatory in all three species. The vaccine reduces by 40% Aβ42 peptide and by 50% tau and phospho-tau in the brains of 3X AD Tg mice, the two main pathologies of Alzheimer’s disease, with high levels of anti-Aβ42 antibody and with a non-inflammatory immune response. He is preparing now a Phase 1 Clinical trial Grant - First in Human to determine its effectiveness and safety in human subjects. He has published 297 original scientific articles, chapters, reviews, and editorials. He served as Editor in Chief from 1997 through 2017 for JAMA Neurology (formerly Archives of Neurology), a major international neurology journal, published by the American Medical Association. During his tenure, he raised the Impact Factor of the journal from 3.0 to 10.2, placing JAMA Neurology as #1 of all US publications in neurology. He is the founding editor of two of the landmark texts in neuroscience. Rosenberg’s Molecular and Genetic Basis of Neurological and Psychiatric Disease, 5th edition, published in 2015 by Elsevier. The 6th edition will publish in 2020. The Atlas of Clinical Neurology, 4th edition, has just been published. He is a former President of the American Academy of Neurology, former Vice-President of the American Neurological Association, an Honorary Member of both organizations, and a Fellow of the American Association for the Advancement of Science. He received the first Science Medal in 2009 from the World Federation of Neurology for his contributions to neuro-genetics, for his original clinical and molecular genetics research on Machado-Joseph disease, and the development of the DNA Abeta42 trimer vaccine for Alzheimer’s disease.

Affiliations and Expertise

Abe (Brunky), Morris and William Zale Distinguished Chair in Neurology, Professor of Neurology and Neurotherapeutics, Founding Director, Alzheimer’s Disease Center Head, Section on Memory and Behavioral Neurology, University of Texas Southwestern Medical Center, Dallas, Texas, USA

Juan M. Pascual

Juan M. Pascual

Juan M. Pascual, M.D., Ph.D., is the inaugural holder of The Once Upon a Time Foundation Professorship in Pediatric Neurologic Diseases and also holds the Ed and Sue Rose Distinguished Professorship in Neurology. His laboratory research interests span virtually the entire field of neuroscience, including medical neuroscience, from molecular structure and function (including drug action), neural physiology and metabolism at the cellular, circuit and whole-brain level and neurogenetics, all of which is complemented with neurological patient care and clinical trials. Laboratory research greatly influences his clinical activities and patient observations guide his laboratory research direction. As a clinician, Dr. Pascual specializes in genetic and metabolic diseases of the nervous and neuromuscular systems of infants, children, and adults with a particular emphasis on complex diagnostic problems, second opinions for patients visiting from the rest of the U.S. and abroad, and in clinical trials. Dr. Pascual has special clinical research expertise in undiagnosed and rare diseases, glucose metabolism, mitochondrial, degenerative, and multi-organ disorders. Dr. Pascual is a tenured faculty member in four Departments at UT Southwestern Medical Center: Neurology and Neurotherapeutics, Physiology, Pediatrics, and the Eugene McDermott Center for Human Growth & Development / Center for Human Genetics. He is also Director of the Rare Brain Disorders Program (Clinic and Laboratory). He is also a member of the Division of Pediatric Neurology, of the graduate Ph.D. programs in Neuroscience and Integrative Biology, and of the postgraduate clinical training programs in Neurology, Pediatric Neurology, Pediatrics, and Medical Genetics. He teaches at UT Southwestern Medical School. In addition, Dr. Pascual is an adjunct professor in the Department of Biological Sciences at the School of Natural Sciences and Mathematics, The University of Texas at Dallas. Dr. Pascual directs a highly collaborative research laboratory and is credentialed campus-wide at Children's Medical Center Dallas, UT Southwestern University Hospitals and Clinics, and Parkland Memorial Hospital, where he consults on inpatients and outpatients with particularly complex or severe diseases. Much of his research is funded by the National Institutes of Health. Dr. Pascual received his M.D. degree with unique distinction from the Universidad de Granada, Spain, one of the oldest universities in the world, founded in 1349 by Yusuf I, Sultan of Granada and one of the builders of the Alhambra. He received his Ph.D. degree in Molecular Physiology and Biophysics from Baylor College of Medicine in Houston, Texas, under Arthur M. Brown, M.D., Ph.D., McCollum Professor and Chair. His postdoctoral research was conducted under Arthur Karlin, Ph.D., Higgins Professor and Director of the Center for Molecular Recognition, College of Physicians and Surgeons of Columbia University and, later, at the Colleen Giblin Research Laboratories for Pediatric Neurology at the same institution under a Neurological Sciences Academic Development Award from the National Institute of Neurological Disorders and Stroke. He also received residency training in Pediatrics at Washington University School of Medicine - St. Louis Children's Hospital and in Neurology and Pediatric Neurology at the Neurological Institute of New York - Columbia University Medical Center. He received certification in Neurology with Special Qualification in Child Neurology from the American Board of Psychiatry and Neurology. As one of few actively practicing pediatric neurologists in the nation who is also a laboratory scientist, Dr. Pascual is interested in the molecular mechanisms that cause inherited metabolic and excitability disorders using electrophysiology and nuclear magnetic resonance (MRI) both in human subjects and in models of human diseases. His laboratory is located in the newest biomedical research building (NL) at UT Southwestern and is an integral part of the Department of Neurology and Neurotherapeutics. The laboratory is home to scientists from very broad backgrounds and levels of training and expertise who have joined efforts to endow both pediatric neurology and human developmental neuroscience with a strong scientific basis. Dr. Pascual has co-authored over two dozen scientific, medical and philosophical textbooks. He is the editor, together with Dr. Roger Rosenberg, of Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease (5th and 6th editions, Academic Press). His textbook Progressive Brain Disorders in Childhood (Cambridge University Press) was published in 2017. He is working on a new book, provisionally entitled Sense & Nonsense in Medical Neuroscience: Inference & Fallacy, to be published by Cambridge University Press. An avid reader and speaker, Dr. Pascual is also interested in the philosophy of mind. He is particularly concerned with the proper study of the human condition. Thus, he is a critic of errors commonly made by cognitive neuroscientists. As a research and clinical neurogeneticist, he has also grown disillusioned with the current simplistic overreliance on genes as an explanation of biology or disease. Dr. Pascual has no interest in - nor is he sponsored by - any business that conducts medical research or lobbies for financial gain.

Affiliations and Expertise

The Once Upon a Time Foundation Professor in Pediatric Neurologic Diseases; Ed and Sue Rose Distinguished Professor in Neurology, Director, Rare Brain Disorders Clinic and Laboratory, Departments of Neurology and Neurotherapeutics, Physiology and Pediatrics; Eugene McDermott Center for Human Growth and Development/Center for Human Genetics, The University of Texas Southwestern Medical Center, Dallas, TX, USA

Ratings and Reviews